Zimmer Biomet Supply Woes Could Leave An Opening In Joint Markets
Zimmer Biomet said it was not able to maintain supply to meet strong demand for its hip, knee and other joint products that grew out of cross-selling opportunities. As a result, the firm fell short of financial expectations in Q3. The company said it is working to improve its supply-chain procedures, but there could be a short-term chance for competitors to make some gains, analysts suggest.
Register for our free email digests: